Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
How GLP-1 Agonists Affect Gene Expression and Promote Pancreatic Health
Researchers at the Salk Institute identified the protein Med14 as the molecular bridge that links GLP‑1 agonist drugs to broad genomic responses that enhance pancreatic beta‑cell health. The team showed that phosphorylation of Med14 is essential for activating gene programs that improve cell viability and insulin output, while a phosphorylation‑deficient Med14 mutant abolishes these benefits. The findings were published in the Proceedings of the National Academy of Sciences on March 4 2026 and were funded by NIH grants and private philanthropy. This mechanistic insight clarifies how long‑acting GLP‑1 drugs deliver sustained metabolic advantages.
Children’s Hospital Deadline Will Be Missed Again, Committee Told
The €2.2 billion (≈$2.42 billion) national children’s hospital in Ireland has missed its 18th deadline, with contractor Bam confirming it will not achieve substantial completion by 30 April 2026. The National Paediatric Hospital Development Board (NPHDB) has invoked contract rights, including withholding 15% of...
The Youngest-Ever Female Fortune 500 CEO Is Reinventing the Largest Medicaid Insurer Amid Funding Cuts and Rising Costs
Sarah London has become the youngest-ever female CEO of a Fortune 500 company, taking the helm of Centene, the nation’s largest Medicaid insurer. She is steering the firm through steep federal Medicaid cuts and rising health‑care costs by trimming non‑core...
The United Laboratories and Novo Nordisk Report P-II Trial Data on UBT251 in Chinese Patients with Type 2 Diabetes
Novo Nordisk and United Laboratories reported Phase‑II data for the GLP‑1 agonist UBT251 in 211 Chinese patients with type‑2 diabetes. Over 24 weeks, UBT251 achieved a 2.16 % HbA1c reduction, outperforming semaglutide’s 1.77 % and placebo’s 0.66 % from a baseline of 8.12 %....
Transcendental Meditation Linked to Lower Cardiovascular Risk in New Cardiology Commentary
A commentary in Nature Reviews Cardiology, authored by researchers from Maharishi International University, UCLA and Wayne State, argues that Transcendental Meditation can lower stress‑related cardiovascular risk. The paper cites decades of trials showing blood‑pressure reductions and slower atherosclerosis progression, and...
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
Gilead announced a $2.1 billion acquisition of Ouro Medicines and its T‑cell engager OM336, planning to split the deal with long‑time partner Galapagos. Johnson & Johnson and Protagonist Therapeutics secured FDA approval for Icotyde, an IL‑23 receptor blocker that becomes Protagonist’s...
Basecamp Research Unveils Trillion Gene Atlas to Boost Longevity Drug Discovery
Basecamp Research has launched the Trillion Gene Atlas, a platform that will collect and model genetic information from more than 100 million species, expanding known evolutionary diversity by roughly 100‑fold. The initiative aims to give AI models a vastly broader biological...
Merck Nears $6B All‑Cash Deal for Terns Pharma to Boost Oncology Portfolio
Merck & Co. is in advanced talks to acquire Terns Pharmaceuticals in an all‑cash transaction valued at about $6 billion. The deal would add a promising rare‑cancer therapy to Merck’s portfolio and could be announced as early as Wednesday.
New York Ends Essential Plan, Cutting Coverage for 460,000 Low‑Income Residents
New York State announced the rollback of its Essential Plan, ending near‑free health insurance for about 460,000 low‑income residents. The move eliminates a key safety‑net, prompting concerns from advocates and insurers about coverage gaps and market disruption.
Magnetic Silk‑Iron Nanoparticles Offer Precise Drug Delivery to Inaccessible Tissues
A multinational research team has created magnetic silk‑iron nanocomposite particles that can be steered with external magnetic fields to deliver therapeutics directly to otherwise inaccessible tissues. The breakthrough promises higher efficacy and lower side‑effects for treatments ranging from cancer to...
Pfizer and Valneva's Lyme Vaccine Shows 73.2% Efficacy in Late‑Stage Trial
Pfizer and French biotech Valneva announced that their experimental Lyme disease vaccine, PF-07307405, achieved 73.2% efficacy in a Phase III trial, marking the most advanced effort to bring a U.S. Lyme vaccine to market despite missing its primary statistical benchmark. The...
Genomic Mapping of E. Coli Capsules Identifies High-Risk Types for Vaccines
A genomic survey of over 18,000 *Escherichia coli* genomes has mapped 90 capsular K‑loci, revealing that five capsule types (K1, K5, K52, K2, K14) cause more than half of bloodstream and urinary‑tract infections in Europe. The study links these high‑risk...
World-First Portable Multi-Pathogen CRISPR Test Seeks to Improve STI Diagnostics
Researchers at Australia’s Peter Doherty Institute have created a portable, CRISPR‑based diagnostic that simultaneously detects syphilis, HSV, chlamydia and gonorrhea in under an hour. The assay also identifies a key antibiotic‑resistance gene in gonorrhea, delivering 97‑100% accuracy compared with laboratory...
MSD and Quotient Collaborate on IBD Drug Targets
Merck (MSD) has entered a multi‑year research partnership with Quotient Therapeutics to uncover new drug targets for inflammatory bowel disease using Quotient’s somatic genomics platform. The deal provides Quotient with $20 million upfront and up to $2.2 billion in regulatory, development and...
US-Style Health Care Is Wrong for the UK
A recent BBC and New Statesman investigation uncovered preventable infant deaths at University Hospitals Sussex NHS Foundation Trust, highlighting a deepening maternal‑health crisis in the United Kingdom. Over the past 15 years, maternal mortality rates have risen steadily, exposing gaps in NHS...
Despite Driving Most Disability Claims, MSK Is Solvable
Musculoskeletal (MSK) conditions remain the top driver of disability claims in the U.S., costing employers billions in lost productivity and medical expenses. The article argues that most of this spend is preventable through early, accessible care rather than reactive, high‑cost...
Benefits of Dental Veneers and Why People Choose Them
In 2024 more than 2.3 million Americans chose dental veneers, a 40% surge from five years earlier. Veneers combine cosmetic transformation with a protective seal that can preserve enamel and stave off costly restorative work such as crowns, which typically cost...
Philips Launches IntraSight Plus to Simplify Coronary Interventions and Advance Precision Care
Royal Philips has launched IntraSight Plus, an FDA‑cleared and CE‑marked interventional cardiology platform that unifies intravascular ultrasound, iFR/FFR physiology, and angiographic imaging on a single screen. The system promises up to 47% reduction in procedure time by streamlining data entry...
Milan Longevity Summit 2026: Designing the $120 Trillion “One Health” Future
The Milan Longevity Summit 2026, held May 20‑23 at Allianz MiCo, convenes leaders across finance, AI, agri‑food, urban design and more to re‑engineer systems for an aging world. Using the One Health framework, the event treats human longevity as intertwined...
Pixee Medical’s Knee+ NexSight Receives the European CE Mark for Knee Arthroplasty
Pixee Medical has secured a European CE mark for its Knee+ NexSight augmented‑reality platform, enabling the first EU total knee arthroplasty procedures using the technology. The system projects a voice‑controlled virtual overlay during surgery, delivering robotic‑level precision without a robot,...
Stock to Buy for Long Term: Ventura Sees 39% Upside in This Healthcare Stock. Should You Buy?
Ventura Securities has initiated coverage on Park Medi World Ltd (PMWL) with a Buy rating and a $3.4 target price, suggesting roughly 38% upside over the next two years. The hospital chain, listed at $2.0 per share, leverages a capital‑efficient...
Ionis’ Zilganersen Receives US FDA Priority Review for Alexander Disease
Ionis Pharmaceuticals received FDA acceptance of its new drug application for zilganersen and a priority‑review designation for treating Alexander disease, with a PDUFA target action date of September 22, 2026. The Phase III trial enrolled 54 patients aged 1.5 to 53...
A Class Action Suits Moves RICO From Mobsters to Medicine
In this episode, attorney Harrison James explains how the Racketeer Influenced and Corrupt Organizations Act (RICO), originally aimed at organized crime, is being used in a landmark civil class action against Takeda Pharmaceuticals and Eli Lilly over the diabetes drug Actos....
Imaging Manufacturer Guerbet Faces Financial Challenges Following Recent FDA Warning
French imaging contrast agent maker Guerbet is confronting a severe FDA warning after inspectors found significant good manufacturing practice violations at its Raleigh, North Carolina plant. The citation has already depressed Americas revenue by 4% year‑over‑year and reduced MRI‑related sales,...
Indian Man Whose Life Support Was Removed After Court Go-Ahead Dies
Harish Rana, a 31‑year‑old Indian man who had been in a coma since a 2013 balcony fall, died at AIIMS after the Supreme Court authorized the removal of his life‑support machines. The decision marks India’s first court‑approved instance of passive...
Fraudster Faces 3 Years in Prison for Role in $14M Imaging-Related Scheme
A Los Angeles woman, Sophia Shaklian, was sentenced to 35 months in federal prison for orchestrating a Medicare fraud scheme that siphoned more than $14 million through fake diagnostic imaging and hospice services. She owned multiple sham providers and submitted fraudulent...
Regulation Is Pushing European Medtech to Streamline Clinical Trial Operations
European medtech firms are scrambling to meet the heightened evidence demands of the EU MDR, IVDR, AI Act and the European Health Data Space. Over half plan to optimise data collection, yet only a third have adopted core digital trial...
Unregistered Dentist Offered Treatment to Patients From Sittingroom of Dublin Apartment
The Irish Dental Council disclosed that an unregistered dentist was providing X‑ray treatments from the sitting‑room of a Dublin apartment, exposing a loophole in the Dentists Act 1985 that prevents regulation of non‑licensed practices. The council reported it could not act...
Reforming Public Health in India
The Lancet Commission proposes a citizen‑centred health system for India, outlining six reform actions. It argues that despite adequate per‑capita funding of roughly $24 in many states, the public sector fails to deliver universal health coverage because budgets are fragmented,...
Advertising to Doctors - Okay or Not? | Out-Of-Pocket
OpenEvidence and DoxGPT are offering free, AI‑driven literature‑review tools for physicians, funded by advertising. The model shifts costs from doctors to pharma, potentially lowering barriers compared with subscription services like UpToDate, which charge $550 per physician annually. Clear separation and...
Medicaid’s Newest Reform Is a Morass of Red Tape
Georgia’s "Pathways to Coverage" Medicaid reform, launched in July 2023, aimed to expand coverage for low‑income workers but enrolled only 8,077 of the 240,000 eligible. The program’s private‑contractor‑run IT platform, built by Deloitte for $528 million, generated frequent form changes and...
The Limits Of Efficiency In Home Health’s Cost-Cutting Era
Home‑based care providers are under intense reimbursement pressure, inflation and staffing shortages, prompting a sharp focus on efficiency. Well Care Health, a 700‑employee provider serving 5,000 daily patients across North and South Carolina, warns that cost‑cutting initiatives, especially AI‑driven ones,...
As Antibiotics Fail, a New Treatment Targets the Host, Not the Bacteria
Researchers at Trinity College Dublin have demonstrated that a single dose of interferon‑gamma can “train” human macrophages to more effectively kill drug‑resistant bacteria such as MRSA and Mycobacterium tuberculosis. The IFN‑γ‑trained cells undergo epigenetic reprogramming, rely on glutamine metabolism, and...
This Tiny Implant, Smaller than a Grain of Salt, Can Read Your Brain
Cornell researchers have unveiled the microscale optoelectronic tetherless electrode (MOTE), a neural implant barely larger than a grain of salt. The 300 µm‑by‑70 µm device wirelessly transmits brain‑wave data via infrared light and has demonstrated chronic operation in awake mice for more...
Cancer Drug Can Treat Drug-Resistant Herpes, Too
Researchers at the University of Illinois Chicago have repurposed the FDA‑approved cancer drug doxorubicin to combat drug‑resistant herpes simplex virus type 1 (HSV‑1). Using their AI‑driven platform HerpDock, they identified doxorubicin’s ability to block the PI3K‑AKT‑mTOR pathway that the virus exploits,...
Lyme Disease Isn’t a Bioweapon, Says Immunology Researcher
Since Lyme Disease is suddenly getting more attention than usual: Hi! I’m a researcher and scientist getting my PhD in Immunology, Infection and Epidemiology. I’ve been studying tick feeding and Lyme Disease for over 5 years now looking for an anti-tick...
Why Are Rates Of Maternal Mortality Rising So Quickly?
Maternal mortality in the United States reached 649 deaths in 2024, a slight decline from 669 in 2023 but still far above historical norms. The surge is driven by two intertwined crises: 2.2 million women of child‑bearing age live in maternity‑care...
CMS Unveils New Pediatric Care Model
CMS announced the Accelerating State Pediatric Innovation Readiness and Effectiveness (ASPIRE) Model, a ten‑year voluntary initiative for up to five states to improve whole‑person care for Medicaid and CHIP beneficiaries up to age 21. The model places accountability for quality...
Remote Robotic Stroke Surgery Triumphs in Panama, Paving Way for Global Tele‑Neurointervention
A neurosurgeon in Santiago performed a remote robotic thrombectomy on a stroke patient at The Panama Clinic, restoring cerebral blood flow within minutes. The breakthrough, part of XCath’s Operation Robo Angel study, demonstrates how AI‑enabled robotics can overcome geographic barriers...
Arson Attack on Jewish Ambulances in London Claimed by Harakat Ashab Al-Yamin Al-Islamia
A little‑known group, Harakat Ashab al‑Yamin al‑Islamia, said it torched four Jewish charity ambulances in London’s Golders Green, warning of further attacks on U.S. and Israeli interests. Police are investigating the arson and a broader wave of antisemitic incidents across Europe,...
Kermit Gosnell, Convicted Abortion Doctor, Dies at 85 in Pennsylvania Prison
Kermit Gosnell, the former West Philadelphia abortion provider convicted of murdering three newborns and a patient, died on March 1 at age 85 while incarcerated at State Correctional Institution‑Smithfield. His death revives discussion over clinic oversight, the abortion‑rights fight and the legacy...
Wearable Health Trackers Spark Privacy Outcry as Big Data Harvest Grows
Consumer groups and regulators warned that data from millions of smartwatches, period‑tracking apps and smart rings is being sold to advertisers and could be subpoenaed in criminal cases. The scrutiny comes as the U.S. smart‑ring market hits 2.6 million units in...
VC Frenzy Risks Unsafe, Profit‑driven Psychedelic Clinics
So I know everyone's really excited about psychedelics and I mean. Me too kind of. You know what I'm not excited about? The fact that every venture capitalist under the sun is throwing money at this right now (trust me, a...
Rubber Dams Enable Precision in Modern Dental Care
Why Rubber Dams Matter in Precision Dental Procedures by @IntEngineering #MedTech #HealthTech #Tech #Healthcare #TechForGood https://t.co/cRySPYX43q
Lenz Therapeutics Misses Q4 Forecast, Shares Slide 11.2%
Lenz Therapeutics reported a Q4 loss of $1.16 per share on $1.6 million in revenue, far below analysts' expectations of a $0.90 loss on $3.1 million. The miss sent the biotech’s shares down 11.2% as investors reacted to higher SG&A costs and...
Perimenopausal Women Remain Grossly Undertreated in Orthopedics
Nearly 30 years in orthopedic surgery. Another pattern that is impossible to ignore. Perimenopausal women are some of the most undertreated patients I see. One unfortunate paper is blamed... but often, it's because the conversation never happens. https://t.co/6m6AxUhRKF
AL-S Pharma Tests How Far SOD1 Biology Extends Into Sporadic ALS
The article outlines BioCentury’s cookie policy, detailing the categories of cookies used on its website—strictly necessary, functional, marketing, advertising, and analytics. Each type is described in terms of purpose, activation status, and impact on user experience. The policy emphasizes that...
Penn Engineers Unveil aroLNPs Cutting Liver Delivery Tenfold While Boosting Lymph‑Node Targeting
University of Pennsylvania bioengineers have created a redesigned lipid nanoparticle, aroLNP, that delivers at least ten‑fold less mRNA to the liver while preserving lymph‑node uptake. The breakthrough could lower the dose needed for effective vaccination and expand mRNA therapeutics.
Exercise Protects Blood‑Brain Barrier, Slowing Alzheimer’s
New on exercise —the best medicine vs age-related chronic diseases, a review @Cell_Metabolism https://t.co/z9RpD0SlYW —salutary effect on the blood brain barrier (BBB) vs Alzheimer's and brain aging gift link https://t.co/jmhJwXGWms by @GretchenReynold —original research on BBB integrity via liver produced exercise factor @CellCellPress https://t.co/3tSN8knpYF
How A Small Rural Hospital Is Using AI to Catch Heart Disease Sooner
Wayne General Hospital in rural Mississippi has adopted Eko Health’s AI‑powered digital stethoscope, allowing clinicians to detect cardiac conditions such as atrial fibrillation, low ejection fraction and valvular disease in real time. The AI engine combines auscultation with ECG data...